City of Hope

États‑Unis d’Amérique


 
Quantité totale PI 956
Quantité totale incluant filiales 1 223 (+ 269 pour les filiales)
Rang # Quantité totale PI 1 381
Note d'activité PI 3,5/5.0    635
Rang # Activité PI 1 131
Activité incl filiales 3,2/5.0    741
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

586 24
54 0
291 0
1
 
Dernier brevet 2025 - Baff-r targeted chimeric antigen...
Premier brevet 1981 - Method of testing for particular...
Dernière marque 2025 - CANCER FIGHTERS
Première marque 1984 - CITY OF HOPE

Filiales

2 subsidiaries with IP (254 patents, 15 trademarks)

1 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Online social networking services in the field of cancer patient support Providing a website feat...
2024 P/S Promoting public awareness of the need for cancer prevention and the need for healthy diets; busi...
P/S Analyzing and compiling business data for natural language and data processing technology, data s...
Invention Baff-r targeted chimeric antigen receptor-modified t-cells and uses thereof. Provided herein are...
Invention Pcna inhibitors and uses thereof. inter aliainter alia, are PCNA inhibitors and uses thereof.
Invention Bispecific antibodies and uses thereof. Provided herein are, inter alia, antibody compounds comp...
Invention T cells for expression of chimeric antigen receptors and other receptors. Methods for preparing ...
Invention M6a mrna modification in cancer treatment. Disclosed herein are methods of treating cancer by in...
Invention Compositions and methods of making and using ipsc-derived car macrophages. inter aliainter alia, ...
Invention Expansion of human group 2 innate lymphoid cells and methods of use thereof. Provided herein, in...
Invention Combination therapy for treatment of cancer. Described herein, inter alia, are combination thera...
Invention Chimeric poxvirus compositions and uses thereof. Provided herein are, inter alia, viral composit...
Invention Multi-specific ligand binders. Provided herein are, inter alia, novel peptide compositions havin...
Invention Pcna inhibitors. Described herein, inter alia, are compositions of PCNA modulators and methods f...
Invention Programmable conditional sirnas and uses thereof. Disclosed herein are programmable, conditional...
Invention Compositions and methods of alleviating resistance to chemotherapy. Disclosed herein are methods...
Invention Adeno-associated virus compositions and methods of use thereof. Provided herein, inter alia, are ...
Invention System, device and method for production of bioproduct including high density cell respirator (hd...
Invention Baff-r antibodies and uses thereof. Provided herein are BAFF-R antibodies as well as composition...
Invention Methods of inducing organ transplantation immune tolerance and associated compositions and method...
Invention Multivalent epstein-barr virus-like particles and uses thereof. Disclosed are vaccine compositio...
Invention Membrane-bound il-12 for cellular immunotherapy. This disclosure relates to, inter alia, cells ex...
Invention Assays for characterization of extracellular vesicles and methods of using the same. Disclosed he...
Invention Cysteine peptide-enabled antibodies. Provided herein are functionalized monoclonal antibodies (m...
Invention Systems and methods related to dosimetry for radioembolization, chemoembolization, and drug eluti...
Invention Ctla-4 aptamer conjugates. Provided herein are, inter alia, nucleic acid compounds useful for ta...
Invention Anti-il1rap antibodies and variants thereof. Provided herein are, inter alia, Interleukin-1 recep...
Invention Engineered anti-prostate stem cell antigen fusion protein and uses thereof. Disclosed are enginee...
Invention Machine learning enabled prognosis of patient mortality. A method for machine learning enabled m...
Invention Mechanically interlocking complexes. Provided herein are functionalized monoclonal antibodies (m...
2023 Invention Stem cells for delivery of oncolytic viruses. inter aliainter alia, are stem cells including an e...
Invention Self-service cohort selection for large-scale observational studies. A method for self-service c...
Invention Compositions comprising myeloid phagocytic cells expressing a chimeric antigen receptor. Describe...
Invention Synthesis of human serum albumin conjugate. Described herein, inter alia, is a method of conjuga...
Invention Treatment of canavan disease. Disclosed herein are methods of treating Canavan disease in a subj...
Invention Recombinant adeno-associated vectors for targeted treatment. Novel adeno-associated virus (AAV) ...
P/S Downloadable computer software platforms for database management and data analytics Platform as a...
Invention Use of endogenous viral vaccine in chimeric antigen receptor t cell therapy. Provided herein are,...
P/S Telemedicine services; Telehealth services; Medical consultations; Medical services
2022 Invention Methods of preventing, treating, or reducing the severity of coronavirus disease 2019 (covid-19)....
Invention Methods of preventing, treating, or reducing the severity of covid-19 in immunocompromised blood ...
Invention Engineering or inducing pdgf and/or pdgfr signaling to enhance nk cell therapy. Provided herein,...
Invention Clostridium butyricum compositions and methods of using the same. Provided herein, inter alia, a...
Invention Anti-cd3 antibodies and uses thereof. Provided herein are, inter alia, antibodies capable of bin...
Invention Novel small molecule inhibitors of pus7 and uses thereof. Disclosed herein are, inter alia, comp...
Invention Methods for detecting dysfunctional nk cells in leukemia patients. Provided herein are, inter al...
Invention Pcna inhibitors and egfr inhibitors for cancer treatment. Described herein are, inter alia, meth...
Invention Cancer treatment by targeting proteins or interactions of ephrinb-rgs3-kif20a-sept7 axis. A meth...
Invention Lipid nanoparticles and methods of use. Provided herein are, inter alia, lipid nanoparticles, li...
Invention Car t cell therapy and ifn gamma. Provided herein are, inter alia, compositions comprising chime...
Invention Anti-hvem antibodies. Provided herein are, inter alia, antibodies (e.g. humanized antibodies, mo...
Invention Truncated domain iv egfr and uses thereof. A truncated EGFR (tEGFR) cell surface molecule and it...
Invention Anti-domain iv egfr antibodies and uses thereof. Provided herein are, inter alia, novel antibodi...
Invention Natural killer cells engineered to reduce or eliminate cbl-b and uses thereof. Described herein ...
2021 Invention Vaccination of hematopoietic stem cell donors with cytomegalovirus triplex composition. Disclose...
2020 P/S Downloadable webinars in the field of medical conditions and diseases; Downloadable webinars in t...
2011 P/S Newsletters in the field of medical care, healthcare, disease and chronic illness information, ca...
P/S Providing temporary housing accommodations to patients and families
P/S Healthcare services
P/S Downloadable electronic newsletters in the field of medical care, healthcare, disease and chronic...
P/S Medical and scientific research, namely, conducting clinical trials
P/S Entertainment and recreational services, namely, providing physical fitness and yoga instruction
P/S Charitable fundraising services
2007 P/S Newsletters in the field of medical care, health care, and disease information
2006 P/S Charitable fundraising services Medical research services Hospital services
1996 P/S telephone information services, namely, providing information regarding diseases
1990 P/S providing incentives to people to demonstrate excellence in humanitarian and social endeavors thr...
1984 P/S Hospital and Medical Research Services